Financial
Latest full-year results from official filings.
FY2025 revenue €17.83bn (-1.0%); operating margin 8.0%; net income €895.0m.
Net debt €5.29bn.
- Official results release · Philips · 31 Dec 2025
Philips: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Aug 2026: ransomware group Cl0p claimed to have taken about 13.5GB of mostly technical drawings. Philips said it contained an attempted compromise of one internal server, with no customer impact.
- Shell and Philips hit by Russian ransomware attack · DutchNews · 14 Aug 2026
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
Aug 2026: attempted compromise of an internal enterprise server (Cl0p claim); Philips said it was contained with no customer impact. NHS DSPT and certification status not yet checked.
- Shell and Philips hit by Russian ransomware attack · DutchNews · 14 Aug 2026
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
Under a 2024 US FDA/DOJ consent decree following the June 2021 Respironics CPAP/BiPAP recall, Philips cannot sell new sleep and respiratory care devices in the US until its facilities comply. Ventilator remediation and testing were still ongoing in May 2026.
- Philips Respironics FAQ (May 2026) · Philips · 6 May 2026
Contract performance
Contract delivery, go-lives, terminations and disputes.
No contract terminations or disputes involving Philips found in HSH's search of the last 24 months.